BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com